Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0001140361-19-004276

Chief Business Officer acquired 1,625 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nolan Lisa Chief Business Officer 2019-02-28 Option exercise +1,625 23,250 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nolan Lisa Chief Business Officer 2019-02-28 Option exercise · Restricted Stock Units −1,625 3,250 D: show line 2 in the form
Loading xslF345X03/form4.xml…